Search research articles
Contact Us
Filters
Showing results (381-390 of 438) with videos related to
Page
of 44
Sort By:
Scientific Reports
|
February 1, 2020
Analysis of the polycystin complex (PCC) in human urinary exosome-like vesicles (ELVs)
Wendy A Lea, Kerri McGreal, Madhulika Sharma, et al.
Journal of Neurology
|
December 28, 2012
The p.Ala510Val mutation in the SPG7 (paraplegin) gene is the most common mutation causing adult onset neurogenetic disease in patients of British ancestry
Richard H Roxburgh, Renate Marquis-Nicholson, Fern Ashton, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 3, 2010
Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124
Douglas S Auld, Scott Lovell, Natasha Thorne, et al.
Neurogenetics
|
February 2, 2012
Confirmation that Xq27 and Xq28 are susceptibility loci for migraine in independent pedigrees and a case-control cohort
B H Maher, M Kerr, H C Cox, et al.
ACS Infectious Diseases
|
January 16, 2020
Characterization of Lead Compounds Targeting the Selenoprotein Thioredoxin Glutathione Reductase for Treatment of Schistosomiasis
Haining Lyu, Pavel A Petukhov, Paul R Banta, et al.
Frontiers in Immunology
|
June 16, 2023
Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis
Alexandre Xavier, Maria Pia Campagna, Vicki E Maltby, et al.
Molecular Biology Reports
|
August 7, 2013
BDNF and TNF-α polymorphisms in memory
B S Yogeetha, L M Haupt, K McKenzie, et al.
Clinical Epigenetics
|
February 11, 2023
Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosis
Maria Pia Campagna, Alexandre Xavier, Jim Stankovich, et al.
Journal of Medicinal Chemistry
|
January 22, 2011
Evaluation of quinazoline analogues as glucocerebrosidase inhibitors with chaperone activity
Juan J Marugan, Wei Zheng, Omid Motabar, et al.
JMIR Research Protocols
|
October 19, 2021
Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study)
Vicki E Maltby, Rodney A Lea, Mastura Monif, et al.
Page
of 44
Search research articles
Search
Showing results (381-390 of 438) with videos related to
Sort By:
Page
of 44
Scientific Reports
|
February 1, 2020
Analysis of the polycystin complex (PCC) in human urinary exosome-like vesicles (ELVs)
Wendy A Lea, Kerri McGreal, Madhulika Sharma, et al.
Journal of Neurology
|
December 28, 2012
The p.Ala510Val mutation in the SPG7 (paraplegin) gene is the most common mutation causing adult onset neurogenetic disease in patients of British ancestry
Richard H Roxburgh, Renate Marquis-Nicholson, Fern Ashton, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 3, 2010
Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124
Douglas S Auld, Scott Lovell, Natasha Thorne, et al.
Neurogenetics
|
February 2, 2012
Confirmation that Xq27 and Xq28 are susceptibility loci for migraine in independent pedigrees and a case-control cohort
B H Maher, M Kerr, H C Cox, et al.
ACS Infectious Diseases
|
January 16, 2020
Characterization of Lead Compounds Targeting the Selenoprotein Thioredoxin Glutathione Reductase for Treatment of Schistosomiasis
Haining Lyu, Pavel A Petukhov, Paul R Banta, et al.
Frontiers in Immunology
|
June 16, 2023
Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis
Alexandre Xavier, Maria Pia Campagna, Vicki E Maltby, et al.
Molecular Biology Reports
|
August 7, 2013
BDNF and TNF-α polymorphisms in memory
B S Yogeetha, L M Haupt, K McKenzie, et al.
Clinical Epigenetics
|
February 11, 2023
Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosis
Maria Pia Campagna, Alexandre Xavier, Jim Stankovich, et al.
Journal of Medicinal Chemistry
|
January 22, 2011
Evaluation of quinazoline analogues as glucocerebrosidase inhibitors with chaperone activity
Juan J Marugan, Wei Zheng, Omid Motabar, et al.
JMIR Research Protocols
|
October 19, 2021
Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study)
Vicki E Maltby, Rodney A Lea, Mastura Monif, et al.
Page
of 44